dc.contributor.author | Flaten, Gøril Eide | |
dc.contributor.author | Luthman, Kristina | |
dc.contributor.author | Vasskog, Terje | |
dc.contributor.author | Brandl, Martin | |
dc.date.accessioned | 2016-03-16T12:46:22Z | |
dc.date.available | 2016-03-16T12:46:22Z | |
dc.date.issued | 2008-07-03 | |
dc.description.abstract | In this study the integrity of the recently developed phospholipid vesicle-based permeability
barrier in the presence of a variety of co-solvents and tensides has been investigated. Also
included are studies of the influence of these additives on drug permeation and the effect of
pH changes on the permeability of ionogenic drug compounds.
Permeability experiments using the hydrophilic model compound calcein together with
polysorbate 80 (Tween 80), polyoxyl 35 castor oil (Cremophor EL), macrogol lauryl ether
(Brij 35), sorbitan monolaurate (Span 20), polyethylene glycol 400 (PEG 400), ethanol and
dimethylsulphoxide (DMSO) were performed to determine whether the barriers were affected
by the presence of these additives in the donor compartment. It was found that the integrity of
the phospholipid vesicle-based barriers did not seem to be influenced by Span 20 up to a
concentration of 5 mg/ml, PEG 400 up to a concentration of 40 mg/ml and ethanol and
DMSO up to a concentration of 20 mg/ml, respectively. Brij 35, Tween 80 and Cremophor
EL were however found to be incompatible with the model at all concentrations as the barriers
became leaky. Appearance of phospholipid in the donor chamber in presence of these three
tensides indicated that the loss of integrity was due to partial dissolution of the phospholipid
vesicles from the barrier. The permeability of testosterone was not significantly improved by
the presence of the different co-solvents, except for 40 mg/ml PEG 400 and 20 mg/ml DMSO
where the permeability was increased.
In the pH study the permeability of metoprolol and naproxen was shown to decrease with
increasing degree of ionisation according to the pH partition hypothesis. This renders the
permeability model suitable for using pH-shift as a factor to influence solubility of drugs as
well as to predict segmental absorption in the gastrointestinal tract. | en_US |
dc.description | © 2008. This manuscript version is made available under the CC-BY-NC-ND 4.0 license (http://creativecommons.org/licenses/by-nc-nd/4.0/) <p>Accepted manuscript version. Published version available at <a href=http://dx.doi.org/10.1016/j.ejps.2008.04.001>http://dx.doi.org/10.1016/j.ejps.2008.04.001</a> | en_US |
dc.identifier.citation | European Journal of Pharmaceutical Sciences 34(2008) nr. 2-3 s. 173-180 | en_US |
dc.identifier.cristinID | FRIDAID 337156 | |
dc.identifier.doi | 10.1016/j.ejps.2008.04.001 | |
dc.identifier.issn | 0928-0987 | |
dc.identifier.uri | https://hdl.handle.net/10037/8982 | |
dc.identifier.urn | URN:NBN:no-uit_munin_8538 | |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier Science | en_US |
dc.rights.accessRights | openAccess | |
dc.subject | VDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Biofarmasi: 736 | en_US |
dc.subject | VDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710::Biopharmacy: 736 | en_US |
dc.subject | Artificial membrane | en_US |
dc.subject | liposomes | en_US |
dc.subject | phospholipid | en_US |
dc.subject | pH | en_US |
dc.subject | bilayer | en_US |
dc.subject | drug permeability | en_US |
dc.subject | tensides | en_US |
dc.subject | surfactants | en_US |
dc.subject | co-solvents | en_US |
dc.subject | flux | en_US |
dc.subject | solubility enhancing agents | en_US |
dc.subject | phospholipid dissolution | en_US |
dc.title | Drug permeability across a phospholipid vesicle-based barrier: 4. The effect of tensides, co-solvent and pH changes on barrier integrity and on drug permeability | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |